News Links
Daily Care for September 23, 2020
Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID (HTML) “It’s not just hacking for the sake of it”: a qualitative study of health innovators’ views on patient-driven open innovations, quality and safety (HTML) PERFORMANCE OF AN AUTOMATED INSULIN DELIVERY (AID) SYSTEM: RESULTS OF EARLY PHASE FEASIBILITY STUDIES (HTML) Use of Personal Continuous Glucose Monitoring Device Is Associated With Reduced Risk of Hypoglycemia in a 16-Week Clinical Trial of People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion (HTML) Long-Term Glycemic Control And Glucose Variability Assessed With Continuous Glucose Monitoring In A Pediatric Population With Type 1 Diabetes: Determination […]
Read MorePress Releases for September 16, 2020
Lilly commits Insulin Value Program, featuring $35 copay card, to suite of affordability solutions for people with diabetes
Read MoreLegislative and Policy News for September 16, 2020
American Diabetes Association Applauds the Ending Health Disparities during COVID-19 (EHDC) Act
Read MoreCeliac News for September 16, 2020
Here are 3 reasons not to self-diagnose ‘gluten intolerance’ Beyond Celiac Encouraged By Increasing Awareness of Economic Burden of Celiac Disease Gluten-free is more than a trend for those with Celiac
Read MorePopular Press for September 16, 2020
Este Haim Says These Were Her First Diabetes Symptoms New Artificial Pancreas Offers Hope for Children with Poorly Controlled Type 1 Diabetes Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?
Read MoreResearch News for September 16, 2020
Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial (HTML) The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study Muscle insulin resistance in type 1 diabetes with coronary artery disease (HTML) Newly-onset type 1 diabetes mellitus precipitated by COVID-19 in an 8-month-old infant (HTML) Epidemiologic Association between Inflammatory Bowel Diseases and Type 1 Diabetes Mellitus: a Meta-Analysis (HTML) Genomic ancestry and metabolic syndrome in individuals with type 1 diabetes from an admixed […]
Read MoreDaily Care for September 16, 2020
COVID-19 and Type 1 Diabetes: Concerns and Challenges (HTML) COVID-19 and diabetes; Possible role of polymorphism and rise of telemedicine (HTML) Glycaemic control in type 1 diabetes mellitus and COVID-19 lockdown: what comes after a “quarantine”? Reduction of hypoglycemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetic patients using flash continuous glucose monitoring: a retrospective cohort study Family Conflict in Type 1 Diabetes: Who is at Risk? Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting – The GoBolus Study (HTML) Training and […]
Read MoreLegislation and Policy News for September 9, 2020
More US States Cap Insulin Cost, but Activists Will ‘Fight Harder’
Read MoreCeliac News for September 9, 2020
Is Bubble Tea Gluten-Free and Safe for Celiacs? Alopecia in Women Linked to Autoimmune Disease, Thyroid Problems Clinical characteristics and long-term health in celiac disease patients diagnosed in early childhood: Large cohort study
Read More